A study by Meyer et al. (2004) suggests that, for SSRIs, 80% occupancy of serotonin transporters (5-HTT) is necessary for an expected treatment effect in depressive episodes in adults (aged 20–50 years). Here, SLC6A4 is linked to major depressive disorder.